Pricing Log in Create free account
Saturday 17 October 2026 Export PFE’s income statement to Excel — free account

Pfizer Inc.

PFE Healthcare Drug Manufacturers General

Pfizer Inc.’s revenue for fiscal 2025 (year ended December 2025) was $62.6 billion, down 1.65% from fiscal 2024. In the quarter to June 2026, revenue grew 2.60%, EPS fell 107.8%, free cash flow grew 125.2% and total debt rose 2.26%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years; insiders bought in the last twelve months.

29.58 0.14 +0.48%
Market cap
$167.8B
P/E
38.9×
Fwd P/E
12.2×
Dividend yield
5.81%
F-score
6/9
Altman Z
2.03
Beneish M
−2.52
Dividend safety
28/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Pfizer Inc. (PFE) Book value per share

Alert me on Book value per share

Pfizer Inc.'s book value per share at the end of fiscal 2025 was 15.3×, unchanged from fiscal 2024. At the end of the quarter to 30 June 2026 it was 15.0×. Over the past ten years it has ranged from 9.8× (fiscal 2016) to 17.1× (fiscal 2022); the current reading is higher than 73% of that period. Pfizer Inc. ranks 10th of 21 Drug Manufacturers General companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2025 15.3× (2.27%)
FY2024 15.6× (1.25%)
FY2023 15.8× (7.49%)
FY2022 17.1× 23.67%
FY2021 13.8× 21.04%
FY2020 11.4× 0.29%
FY2019 11.4× 4.93%
FY2018 10.9× (9.54%)
FY2017 12.0× 22.13%
FY2016 9.8× (6.62%)

Quarterly newest first

Period Book value per share Change
Jun 2026 15.0× (5.57%)
Mar 2026 15.9× 4.04%
Dec 2025 15.3× (6.76%)
Sep 2025 16.4× 4.59%
42 more quarters

Against its own ten years

Low 9.8× High 17.1×
Ten-year median 12.0×
Current reading's percentile 73

Book value per share against peers

Company Book value per share
SNY Sanofi compare 33.8×
AZN AstraZeneca PLC compare 32.5×
NVS Novartis AG compare 22.0×
AMGN Amgen Inc. compare 21.6×
PFE Pfizer Inc. 15.0×
GSK GSK PLC Sponsored ADR compare 11.5×
BMY Bristol Myers Squibb Company compare 10.9×
GILD Gilead Sciences, Inc. compare 9.4×
NVO Novo Nordisk A/S compare 7.8×

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on PFE